Divya Anjana Shankar, MD
Clinical Instructor, Medicine
Biography
Divya Anjana Shankar, MD is a fellow at the Boston University Pulmonary Center. In 2017, she graduated from Chobanian and Avedisian School of Medicine and went on to complete the Boston Medical Center Internal Medicine Residency Program.
Other Positions
- Fellow, Pulmonary & Critical Care Medicine, Boston Medical Center
Publications
- Published on 1/19/2024
Kearney CM, Sangani R, Shankar D, O'Connor GT, Law AC, Walkey AJ, Bosch NA. Comparative Effectiveness of Mepolizumab, Benralizumab and Dupilumab among Patients with Difficult-to-Control Asthma. Ann Am Thorac Soc. 2024 Jan 19. PMID: 38241013.
Read at: PubMed - Published on 1/1/2024
Shankar DA, Hawkins F, Alysandratos KD, Wilson KC, Walkey AJ, Bosch NA, Law AC. Uptake of Antifibrotics for Patients with Idiopathic Pulmonary Fibrosis: 2016-2022. Ann Am Thorac Soc. 2024 Jan; 21(1):170-173. PMID: 37879035.
Read at: PubMed - Published on 6/1/2023
Pang B, Kearney L, Maccarone J, Zhang J, Kearney C, Sangani R, Shankar DA, Gillmeyer KR, Law AC, Bosch NA. Association between Early Venous Thromboembolism Prophylaxis, Bleeding Risk, and Venous Thromboembolism among Critically Ill Patients with Thrombocytopenia. Ann Am Thorac Soc. 2023 Jun; 20(6):917-920. PMID: 36867519.
Read at: PubMed - Published on 4/15/2023
Mesfin N, Sangani R, Shankar DA, Reardon C. New Frontiers in Therapeutics for Interstitial Lung Diseases. Am J Respir Crit Care Med. 2023 Apr 15; 207(8):1089-1091. PMID: 36735934.
Read at: PubMed - Published on 4/3/2023
Shankar DA, Bosch NA, Walkey AJ, Law AC. Practice Changes Among Patients Without COVID-19 Receiving Mechanical Ventilation During the Early COVID-19 Pandemic. Crit Care Explor. 2023 Apr; 5(4):e0889. PMID: 37025306.
Read at: PubMed - Published on 4/1/2023
Shankar DA, Walkey AJ, Hawkins FJ, Bosch NA, Peterson D, Law AC. Hospital-level variation in practices and outcomes for patients with severe acute exacerbations of idiopathic pulmonary fibrosis: a retrospective multicentre cohort study. BMJ Open Respir Res. 2023 Apr; 10(1). PMID: 37076251.
Read at: PubMed - Published on 9/1/2022
Kathuria H, Shankar D, Cobb V, Newman J, Bulekova K, Werntz S, Borrelli B. Integrating Social Determinants of Health With Tobacco Treatment for Individuals With Opioid Use Disorder: Feasibility and Acceptability Study of Delivery Through Text Messaging. JMIR Form Res. 2022 Sep 01; 6(9):e36919. PMID: 36048509.
Read at: PubMed - Published on 4/6/2022
Shankar D, Borrelli B, Cobb V, Quintiliani LM, Palfai T, Weinstein Z, Bulekova K, Kathuria H. Text-messaging to promote smoking cessation among individuals with opioid use disorder: quantitative and qualitative evaluation. BMC Public Health. 2022 Apr 06; 22(1):668. PMID: 35387648.
Read at: PubMed - Published on 4/1/2020
Bhat S, Altajar S, Shankar D, Zahorian T, Robert R, Qazi T, Shah B, Farraye FA. Process and Clinical Outcomes of a Biosimilar Adoption Program with Infliximab-Dyyb. J Manag Care Spec Pharm. 2020 Apr; 26(4):410-416. PMID: 32223602.
Read at: PubMed - Published on 5/1/2017
Shankar DA, Itani KMF, O'Brien WJ, Sanchez VM. Factors Associated With Long-term Outcomes of Umbilical Hernia Repair. JAMA Surg. 2017 May 01; 152(5):461-466. PMID: 28122076.
Read at: PubMed